Shilpa Medicare Limited

NSEI:SHILPAMED Stock Report

Market Cap: ₹70.8b

Shilpa Medicare Future Growth

Future criteria checks 5/6

Shilpa Medicare is forecast to grow earnings and revenue by 77.1% and 29.2% per annum respectively. EPS is expected to grow by 76.5% per annum. Return on equity is forecast to be 14.1% in 3 years.

Key information

77.1%

Earnings growth rate

76.5%

EPS growth rate

Pharmaceuticals earnings growth17.7%
Revenue growth rate29.2%
Future return on equity14.1%
Analyst coverage

Low

Last updated18 Nov 2024

Recent future growth updates

Recent updates

These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Reasonably Well

Jan 02
These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Reasonably Well

What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Sep 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

Jul 05
Shilpa Medicare Limited's (NSE:SHILPAMED) 29% Price Boost Is Out Of Tune With Revenues

What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Apr 12
What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You

Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Feb 21
Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up

Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

Jan 02
Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt

These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Jul 17
These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively

Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Mar 17
Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt

Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Sep 07
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Aug 14
Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10

Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Jan 27
Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load

Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Sep 21
Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why

Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

Jun 17
Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?

If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

May 31
If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late

Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 07
Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Feb 20
Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year

Earnings and Revenue Growth Forecasts

NSEI:SHILPAMED - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202726,7206,215N/A5,7261
3/31/202617,0943,648N/A3,5052
3/31/202514,4131,3403542,7041
9/30/202412,163611-4521,500N/A
6/30/202411,839448N/AN/AN/A
3/31/202411,531319-4921,353N/A
12/31/202311,248-7N/AN/AN/A
9/30/202311,008-119-302,523N/A
6/30/202310,491-321N/AN/AN/A
3/31/202310,517-325-4671,799N/A
12/31/202211,28651N/AN/AN/A
9/30/202211,384213-1,6201,651N/A
6/30/202211,693599N/AN/AN/A
3/31/202211,469607-2,2671,051N/A
12/31/202110,135395N/AN/AN/A
9/30/20219,324376-2,589478N/A
6/30/20219,156631N/AN/AN/A
3/31/20219,0161,478-3,073469N/A
12/31/20209,1351,739N/AN/AN/A
9/30/20209,5912,213-2,704793N/A
6/30/20209,6982,267N/AN/AN/A
3/31/20209,0821,562-2,2491,244N/A
12/31/20198,8761,455N/AN/AN/A
9/30/20198,2411,029-3,065819N/A
6/30/20196,962944N/AN/AN/A
3/31/20197,3371,123-1,5321,468N/A
12/31/20187,6931,193N/AN/AN/A
9/30/20187,8141,281N/AN/AN/A
6/30/20188,2111,167N/AN/AN/A
3/31/20187,8941,052N/A449N/A
12/31/20177,7561,133N/AN/AN/A
9/30/20177,7311,149N/AN/AN/A
6/30/20177,7871,190N/AN/AN/A
3/31/20177,7951,076N/A375N/A
12/31/20167,5651,048N/AN/AN/A
9/30/20167,7351,153N/AN/AN/A
6/30/20167,3691,024N/AN/AN/A
3/31/20167,1661,083N/A1,287N/A
12/31/20156,867886N/AN/AN/A
9/30/20156,430776N/AN/AN/A
6/30/20156,234728N/AN/AN/A
3/31/20156,138737N/A688N/A
12/31/20146,145731N/AN/AN/A
9/30/20146,143798N/AN/AN/A
6/30/20145,966787N/AN/AN/A
3/31/20145,714757N/A700N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SHILPAMED's forecast earnings growth (77.1% per year) is above the savings rate (6.7%).

Earnings vs Market: SHILPAMED's earnings (77.1% per year) are forecast to grow faster than the Indian market (18.1% per year).

High Growth Earnings: SHILPAMED's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SHILPAMED's revenue (29.2% per year) is forecast to grow faster than the Indian market (10.6% per year).

High Growth Revenue: SHILPAMED's revenue (29.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SHILPAMED's Return on Equity is forecast to be low in 3 years time (14.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 22:55
End of Day Share Price 2025/01/06 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shilpa Medicare Limited is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAntique Stockbroking Ltd.
Harith AhamedAvendus Spark
Prathamesh MasdekarBP Wealth Management Private Limited